MSV
ABBV icon

MN Services Vermogensbeheer’s AbbVie ABBV Stock Holding History

MN Services Vermogensbeheer’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149M Sell
684,459
-700
-0.1% -$155K 0.98% 16
2025
Q4 		$157M Buy
685,159
+14,655
+2% +$3.34M 0.96% 14
2025
Q3 		$155M Buy
670,504
+9,200
+1% +$1.87M 1% 17
2025
Q2 		$123M Buy
661,304
+12,200
+2% +$2.27M 0.85% 19
2025
Q1 		$136M Sell
649,104
-48,300
-7% -$9.39M 1.05% 17
2024
Q4 		$124M Buy
697,404
+13,200
+2% +$2.43M 0.84% 20
2024
Q3 		$135M Sell
684,204
-13,600
-2% -$2.54M 0.95% 17
2024
Q2 		$120M Sell
697,804
-17,900
-3% -$2.97M 0.86% 19
2024
Q1 		$130M Sell
715,704
-121,200
-14% -$20.9M 0.95% 19
2023
Q4 		$130M Sell
836,904
-20,400
-2% -$2.97M 1.17% 15
2023
Q3 		$128M Buy
857,304
+14,500
+2% +$2.13M 1.23% 13
2023
Q2 		$114M Sell
842,804
-37,300
-4% -$5.47M 1.06% 17
2023
Q1 		$140M Buy
880,104
+30,400
+4% +$4.65M 1.45% 8
2022
Q4 		$137M Sell
849,704
-132,000
-13% -$20.2M 1.54% 7
2022
Q3 		$132M Sell
981,704
-61,600
-6% -$8.84M 1.39% 11
2022
Q2 		$160M Sell
1,043,304
-220,400
-17% -$33.7M 1.49% 8
2022
Q1 		$205M Sell
1,263,704
-83,900
-6% -$12.2M 1.36% 11
2021
Q4 		$182M Buy
1,347,604
+29,400
+2% +$3.47M 1.07% 19
2021
Q3 		$142M Buy
1,318,204
+23,200
+2% +$2.65M 0.88% 23
2021
Q2 		$123M Buy
+1,295,004
New +$146M 0.96% 22
2020
Q4 		$167M Buy
1,554,404
+19,100
+1% +$1.84M 1.18% 20
2020
Q3 		$134M Buy
1,535,304
+30,300
+2% +$2.85M 1.06% 22
2020
Q2 		$148M Buy
1,505,004
+241,300
+19% +$21.2M 1.26% 20
2020
Q1 		$96.3M Sell
1,263,704
-78,500
-6% -$6.69M 1.08% 23
2019
Q4 		$119M Buy
1,342,204
+44,100
+3% +$3.66M 1.01% 23
2019
Q3 		$98.3M Buy
1,298,104
+543,010
+72% +$37.2M 0.91% 26
2019
Q2 		$54.9M Sell
755,094
-83,500
-10% -$6.56M 0.65% 31
2019
Q1 		$67.6M Buy
838,594
+4,500
+0.5% +$368K 0.78% 28
2018
Q4 		$67.3M Buy
834,094
+592,404
+245% +$52.1M 1.02% 18
2018
Q3 		$22.9M Hold
241,690
– – 0.54% 37
2018
Q2 		$22.4M Sell
241,690
-9,400
-4% -$918K 0.56% 34
2018
Q1 		$23.8M Buy
251,090
+2,500
+1% +$275K 0.62% 30
2017
Q4 		$20M Sell
248,590
-13,900
-5% -$1.31M 0.63% 30
2017
Q3 		$23.3M Buy
262,490
+1,900
+0.7% +$145K 0.61% 33
2017
Q2 		$18.9M Buy
260,590
+217,244
+501% +$14.6M 0.52% 37
2017
Q1 		$2.64M Buy
43,346
+1,190
+3% +$74.8K 0.51% 38
2016
Q4 		$2.5M Buy
42,156
+315
+0.8% +$19.2K 0.51% 38
2016
Q3 		$2.64M Buy
41,841
+946
+2% +$61.2K 0.53% 39
2016
Q2 		$2.28M Sell
40,895
-80
-0.2% -$4.88K 0.53% 42
2016
Q1 		$2.05M Buy
+40,975
New +$2.28M 0.48% 43

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MN Services Vermogensbeheer's ABBV Position: Q1 2026 in Review

MN Services Vermogensbeheer reduced its AbbVie (ABBV) stake by 0.1% in Q1 2026, selling an estimated $155K and leaving 684,459 shares worth $149M. The position accounts for 0.98% of the portfolio, ranked #16.

MN Services Vermogensbeheer first reported a position in ABBV in Q1 2016 and has held it in 40 quarters since. The position peaked at $205M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MN Services Vermogensbeheer held 684,459 shares of AbbVie worth $149M as of Q1 2026.
  • MN Services Vermogensbeheer sold 700 AbbVie shares in Q1 2026, an estimated $155K.
  • AbbVie made up 0.98% of MN Services Vermogensbeheer's portfolio in Q1 2026, its #16 holding.
  • MN Services Vermogensbeheer first reported a position in AbbVie in Q1 2016 and has held it in 40 quarters since.
  • MN Services Vermogensbeheer's AbbVie position peaked at $205M in Q1 2022.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.